by Jordana Choucair | Nov 30, 2022 | Public Health/Prevention
The Centers for Disease Control and Prevention (CDC) announced it is awarding $3.2 billion to help strengthen public health workforce and infrastructure across the U.S. after the COVID-19 pandemic put severe stress on them. The funding includes $3 billion from the...
by Jordana Choucair | Nov 29, 2022 | Life Sciences
Research published in JAMA Internal Medicine revealed that Food and Drug Administration (FDA) approvals of “skinny labels” on biosimilars saved Medicare over $1 billion over five years. According to the research, the FDA approved 33 biosimilars based on 11...
by Jordana Choucair | Nov 29, 2022 | M&A
AstraZeneca PLC announced it will acquire Neogene Therapeutics Inc. in a deal worth up to $320 million, growing the company’s oncology portfolio. The transaction is expected to close in the first quarter of 2023, subject to customary closing conditions and...
by Jordana Choucair | Nov 29, 2022 | M&A
Boston Scientific announced it entered a definitive agreement to acquire Apollo Endosurgery for a cash price of $10 per share to reflect an enterprise value of approximately $615 million. Apollo Endosurgery anticipates net sales of approximately $76 million in the...
by Jordana Choucair | Nov 29, 2022 | Opioid/Substance Use Disorders
The Department of Health and Human Services (HHS) proposed a rule to align 42 CFR Part 2 privacy protections with HIPAA. The rule would require one-time patient consent for disclosure of treatment and allowing HIPAA-covered entities to access those records. The rule...
Recent Comments